Suppr超能文献

123I-碘氟潘单光子发射计算机断层扫描(DaTscan)在运动障碍中心的临床影响

Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.

作者信息

Graebner Allison K, Tarsy Daniel, Shih Ludy C, Vanderhorst Veronique, Kulkarni Omesh, Kaplan Scott, Simon David K

机构信息

Parkinson's Disease and Movement Disorders Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass., USA.

出版信息

Neurodegener Dis. 2017;17(1):38-43. doi: 10.1159/000447561. Epub 2016 Sep 10.

Abstract

BACKGROUND/AIMS: The clinical diagnosis of degenerative forms of parkinsonism is imperfect, with past studies reporting a high rate of misdiagnosis by neurologists and movement disorder specialists, particularly early in the disease course. 123I-ioflupane SPECT (DaTscan) is a diagnostic neuroimaging tool used to distinguish essential tremor from tremor due to degenerative parkinsonisms. The present study expands upon prior studies of the clinical impact of DaTscan imaging in movement disorder centers by assessing quantitative estimates of diagnostic certainty, the impact on subsequent clinical decisions, and the degree to which the asymmetry in the results corresponds to laterality by clinical history and examination.

METHODS

In a prospective, observational study of the impact of DaTscan imaging in a movement disorder center over the course of 18 months, 4 specialists completed a questionnaire at the time they ordered imaging and again within 1 month after imaging.

RESULTS

Twenty-seven patients underwent DaTscan imaging; the result was normal in 4 cases (14.8%), abnormal in 22 cases (81.4%), and equivocal in 1 case (3.7%). In all cases of a normal result, the post-scan-predicted chance of degenerative parkinsonism decreased compared to the pre-scan prediction (p < 0.05), and in all cases of abnormal scan, the post-scan chance of degenerative parkinsonism increased or remained high (p < 0.0001). Clinical impacts were observed following imaging in a total of 24 patients (88.9%), including changes in medications for 18 patients and psychological impacts for 11 patients. Asymmetric clinical symptoms were corroborated based on the expected asymmetry of dopamine uptake deficits in 57.1% of the cases, were not present in 23.8%, and were opposite of expectations in 19.0% of the scans.

CONCLUSION

DaTscan imaging results have an impact on physician's confidence in the diagnosis of parkinsonism and may also have a psychological impact on patients. DaTscan imaging may be a useful adjunct to clinical history and examination in selected patients.

摘要

背景/目的:帕金森病退行性形式的临床诊断并不完善,过去的研究报告称神经科医生和运动障碍专家误诊率很高,尤其是在疾病病程早期。123I-碘氟潘单光子发射计算机断层扫描(DaTscan)是一种诊断性神经影像学工具,用于区分特发性震颤与退行性帕金森病所致震颤。本研究通过评估诊断确定性的定量估计、对后续临床决策的影响以及结果不对称与临床病史和检查所确定的偏侧性的对应程度,扩展了先前关于DaTscan成像在运动障碍中心临床影响的研究。

方法

在一项对运动障碍中心进行的为期18个月的DaTscan成像影响的前瞻性观察研究中,4位专家在开具成像检查时以及成像后1个月内分别填写了一份问卷。

结果

27例患者接受了DaTscan成像;结果正常的有4例(14.8%),异常的有22例(81.4%),不明确的有1例(3.7%)。在所有结果正常的病例中,扫描后预测的退行性帕金森病可能性相较于扫描前预测降低(p < 0.05),而在所有扫描异常的病例中,扫描后退行性帕金森病的可能性增加或保持在高位(p < 0.0001)。共有24例患者(88.9%)成像后出现了临床影响,包括18例患者的药物调整和11例患者的心理影响。基于多巴胺摄取缺陷预期的不对称性,57.1%的病例中不对称临床症状得到证实,23.8%的病例中不存在不对称临床症状,19.0%的扫描结果与预期相反。

结论

DaTscan成像结果会影响医生对帕金森病诊断的信心,也可能对患者产生心理影响。对于部分患者,DaTscan成像可能是临床病史和检查的有用辅助手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验